D-TACE-HAIC Combined With Envafolimab and Lenvatinib for Unresectable ICC

Abroad (travel likely)Recruiting

Conditions

Intrahepatic Cholangiocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fujian Provincial Hospital, Fuzhou, Fujian, China
Contact: Study coordinator (Mao-Lin Yan) · yanmaolin74@163.com · 0591-88217140

Study leads

Maolin Yan, Doctor
Study Chair
Department of Hepatobiliary Pancreatic Surgery, Fujian Provincial Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial)

Intrahepatic Cholangiocarcinoma (Icc) · HAIC · Durvalumab

Abroad (travel likely)RecruitingPHASE2

Chengdu, China

Cryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma (Icc)

Abroad (travel likely)RecruitingPHASE2

Shanghai, China

TACE Combined With Tislelizumab in Patients With Advanced Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma

Abroad (travel likely)RecruitingPHASE2

Shanghai, China

Lenvatinib Plus Sintilimab in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Liver Cancer

Intrahepatic Cholangiocarcinoma

Abroad (travel likely)RecruitingPHASE2

Shanghai, China